-
1 week ago | 
mlo-online.com | Erin Brady
The Directors, Quality, Safety & Oversight Group (QSOG) and Survey & Operations Group (SOG) have published CMS-2567: Statement of Deficiencies and Plan of Correction. The memo aims to help patients receive straightforward healthcare so they can make the best decisions about their care.
-
1 week ago | 
mlo-online.com | Erin Brady
Mayo Clinic has opened the Duan Family Building to make aggressive cancer treatment more accessible, according to an announcement. • None The first carbon ion therapy program in the Americas, projected to be available by 2028
-
1 week ago | 
mlo-online.com | Erin Brady
Indiana University School of Medicine professor Jeff Dage, PhD’s research aided the Food and Drug Administration (FDA) clearance of Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, according to a release. Dr. Dage “helped lead the discovery and development of one of the biomarkers the test identifies.” He hopes it will help broaden the accessibility of Alzheimer's testing.
-
1 week ago | 
mlo-online.com | Erin Brady
A recent UCLA-led study found that it takes people experiencing symptoms of COVID longer to recover mentally than physically. According to a release, “people with COVID-like symptoms returned to optimal physical well-being an average of three months after infection but took up to nine months to return to top mental well-being.” 20% of participants still reported a low quality of life due to their health one year after being sick.
-
1 week ago | 
mlo-online.com | Erin Brady
An Alzheimer’s disease gene therapy has been produced by University of California San Diego School of Medicine scientists “that could help protect the brain from damage and preserve cognitive function,” according to a release. The new therapy could lead researches to “the root cause of Alzheimer’s disease by influencing the behavior of brain cells themselves.” The developers hope their therapy will intervene with Alzheimer's progression. Future studies are needed to test the therapy on humans.
-
2 weeks ago | 
mlo-online.com | Erin Brady
Recent Mayo Clinic research supports the reliability of the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio for diagnosing Alzheimer's, according to a release. The test, recently approved by the FDA, “can be used at outpatient memory clinics to diagnose the disease in patients with a range of cognitive impairment.”Key findings:·The blood test showed accuracy comparable to cerebrospinal fluid biomarkers in an outpatient clinic.
-
2 weeks ago | 
mlo-online.com | Erin Brady
A group of specialists from the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) released findings revealing a high amount of adults living in the U.S. don’t know they have diabetes, high blood pressure, or high cholesterol. Key findings:·Percentages of people unaware of these conditions were highest among young adults. ·Hypertension unawareness increased the most. Diabetes and high cholesterol unawareness stayed the same.
-
2 weeks ago | 
mlo-online.com | Erin Brady
A new study from The University of Texas MDAnderson Cancer Center found that more women will screen for human papillomavirus (HPV) if they can self-test at home. According to a release, screening rates “more than doubled” among women who are under-screened or had never been screened. More than 2,000 diverse women participated in the study. All were reminded to screen by phone. Some received the self-collection kit while others received a reminder to make an appointment with their clinicians.
-
2 weeks ago | 
mlo-online.com | Erin Brady
When given the option to prolong hormone-based breast cancer treatment, many patients chose to, new research finds. A new study led by University of Michigan Health Rogel Cancer Center and Stanford Medicine scientists concluded:·Nearly half of early-stage breast cancer patients (47%) decided to extend their treatment to 10 years after finishing five. ·62% of stage 2 patients said they would extend their treatment. ·39% of stage 1 patients were willing to prolong treatment.
-
2 weeks ago | 
mlo-online.com | Erin Brady
The U.S. Department of Health and Human Services has announced that all 17 members of the Advisory Committee for Immunization Practices (ACIP) have been dismissed. According to an announcement, new members will be selected, and candidates are already being considered. The goal of this action is to reinstate trust in vaccines and “ensure that government scientific activities are informed by the most credible, reliable, and impartial scientific evidence available.” HHS Secretary Robert F.
